Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

VRAX

Virax Biolabs Group Ltd

May 14 • 09:36AM ET

0.7850

Dollar change -0.0083
Percentage change -1.05	%

Healthcare • Biotechnology • United Kingdom • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-4.22	Insider Own	26.80%	Shs Outstand	2.36M	Perf Week	7.53%
Market Cap	1.85M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	1.73M	Perf Month	16.30%
Income	-6.92M	PEG	-	EPS next Q	-	Inst Own	5.65%	Short Float	0.04%	Perf Quarter	-5.26%
Sales	0.08M	P/S	23.16	EPS this Y	-	Inst Trans	-	Short Ratio	0.02	Perf Half Y	-70.04%
Book/sh	3.50	P/B	0.22	EPS next Y	-	ROA	-112.36%	Short Interest	0.00M	Perf Year	-77.76%
Cash/sh	2.17	P/C	0.36	EPS next 5Y	-	ROE	-129.10%	52W Range	0.60 - 5.45	Perf YTD	-46.23%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-107.09%	52W High	-85.58%	Beta	1.04
Dividend TTM	-	Quick Ratio	7.56	Sales past 5Y	-25.34%	Gross Margin	11.39%	52W Low	30.83%	ATR (14)	0.08
Dividend Ex-Date	-	Current Ratio	7.59	EPS Y/Y TTM	-87.22%	Oper. Margin	-8825.12%	RSI (14)	57.12	Volatility	14.80% 12.11%
Employees	11	Debt/Eq	0.03	Sales Y/Y TTM	1276.75%	Profit Margin	-8730.70%	Recom	-	Target Price	-
Option/Short	No / Yes	LT Debt/Eq	0.02	EPS Q/Q	-32.41%	Payout	-	Rel Volume	1.04	Prev Close	0.79
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	1228.12%	Earnings	-	Avg Volume	36.60K	Price	0.79
SMA20	15.07%	SMA50	2.85%	SMA200	-59.84%	Trades		Volume	4,026	Change	-1.05%

Apr-25-24 09:45AM	EXCLUSIVE: Virax Biolabs Launches Immune Profiling Solutions To Evaluate Adaptive Immunity In Post-Viral Syndromes (Benzinga) +5.49%
08:00AM	Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024 (PR Newswire)
Apr-16-24 07:30AM	Virax Biolabs to Participate at ESCMID Global 2024 (PR Newswire)
Mar-15-24 04:30PM	Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency (PR Newswire)
Dec-21-23 07:30AM	Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients (PR Newswire) -14.63%
07:30AM	Loading…
Dec-18-23 07:30AM	Virax Biolabs' CEO James Foster Issues Letter to Shareholders (PR Newswire) -11.84%
Dec-14-23 07:30AM	Virax Biolabs Group Limited Announces 1-for-10 Share Consolidation (PR Newswire)
Sep-21-23 12:21PM	VRAX: Virax Biolabs transformative preventive diagnostic platform supports higher stock price. (Zacks)
Sep-12-23 07:30AM	Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts Webinar (PR Newswire)
Sep-01-23 07:30AM	Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum (PR Newswire)
Aug-03-23 07:30AM	Nasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 Bid (PR Newswire)
Jul-18-23 07:30AM	Virax Biolabs Group Continues Growth and Expansion with the Addition of Research and Laboratory Facilities (PR Newswire)
Jun-21-23 12:14PM	VRAX: Virax Biolabs releases shareholder letter and financial results for the fiscal year ending March 31, 2023. (Zacks Small Cap Research)
Jun-14-23 07:30AM	Virax Biolabs' CEO James Foster Issues Letter to Shareholders (PR Newswire) +24.16%
May-05-23 08:19AM	VRAX: UPDATE: Innovative biotechnology company developing a potentially groundbreaking immunology platform based around proprietary T-Cell testing technology. (Zacks Small Cap Research)
07:30AM	Loading…
May-04-23 07:30AM	Virax Biolabs Group Announces Establishment of Regional Headquarters at Dubai Science Park (PR Newswire) -8.58%
Apr-19-23 07:30AM	Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits (PR Newswire) -7.21%
Mar-10-23 05:17PM	Virax Biolabs Group Limited Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules (PR Newswire) -5.43%
Mar-08-23 08:55AM	Virax Biolabs Group Limited Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules (PR Newswire) -11.57%
Mar-07-23 09:15AM	EXCLUSIVE: Virax Biolabs Starts Distribution Of Avian Flu Test Kits In Europe (Benzinga) +82.53%
07:30AM	Virax Biolabs Group Limited Introduces Avian Influenza A Virus Real-Time PCR Test Kit (PR Newswire)
Feb-16-23 07:12AM	VRAX: INITIATION: Innovative biotechnology company developing a potentially groundbreaking immunology platform based around proprietary T-Cell testing technology (Zacks Small Cap Research)
Feb-07-23 10:07AM	New York City scraps COVID vaccine mandate for public-sector workers. This is the right moment for this decision, Mayor Adams says. (MarketWatch) +6.16%
08:30AM	Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health (NASDAQ:COSM) (PR Newswire)
Feb-06-23 04:05PM	Virax Biolabs to Present at the 2023 BIO CEO & Investor Conference (PR Newswire)
Feb-02-23 07:30AM	Virax Biolabs' CEO James Foster Issues Letter to Shareholders (PR Newswire) +6.89%
Jan-04-23 07:30AM	Virax Biolabs Introduces Human Papillomavirus ("HPV") Test Kit (PR Newswire) +7.07%
07:00AM	EXCLUSIVE: Virax Biolabs Introduces Human Papillomavirus Test Kit In European Union (Benzinga)
Dec-13-22 03:52PM	10 Biotech Stocks With The Biggest Upside (Insider Monkey) -8.40%
Dec-06-22 07:30AM	COVID-19 Rapid Antigen Test Distributed By Virax Biolabs Receives Emergency Use Authorization in the United States (PR Newswire) -5.11%
07:30AM	Loading…
Nov-15-22 07:30AM	Virax Biolabs Appoints Richard Pallin as the Vice President of In Vitro Diagnostic Sales (PR Newswire)
Nov-08-22 04:30PM	Virax Biolabs Group Limited Announces Closing of $3.8 Million Private Placement (PR Newswire) -12.50%
Nov-04-22 07:30AM	Virax Biolabs Group Limited Announces $3.8 Million Private Placement (PR Newswire) -27.51%
Nov-03-22 11:02AM	Weekly tally of COVID cases and deaths continues to fall; Moderna lowers vaccine-sales outlook by as much as $3 billion (MarketWatch) +36.31%
07:30AM	Virax Biolabs Introduces RSV-Influenza-COVID Triple Virus Antigen Rapid Test Kit (PR Newswire)
07:10AM	EXCLUSIVE: Virax Biolabs Launches RSV/Flu/COVID-19 Combo Rapid Test Kit In Europe (Benzinga)
Oct-26-22 07:30AM	Virax Biolabs Group Limited Announces Initiation of its Virax Immune COVID-19 Analytical Performance Study (PR Newswire)
Sep-22-22 07:30AM	Virax Biolabs Group Limited Announces Distribution Agreement to Market Monkeypox Virus Real-Time PCR Detection Kit with Cosmos Holdings Inc. (PR Newswire) +7.89%
Sep-20-22 07:30AM	Virax Biolabs Introduces Monkeypox Virus Antigen Rapid Test Kit (PR Newswire) +41.30%
07:15AM	EXCLUSIVE: Newly Listed Virax Biolabs Launches Monkeypox Antigen Rapid Test (Benzinga)
Sep-12-22 09:17AM	10 Best Penny Stocks to Buy in September (Insider Monkey)
07:00AM	Virax BioLabs Presents at H.C. Wainwright's 24th Annual Global Investment Conference (PR Newswire)
Sep-06-22 04:00PM	Virax Biolabs Group Limited to Present at H.C. Wainwright's 24th Annual Global Investment Conference in New York, NY (PR Newswire) -10.61%
Aug-16-22 07:30AM	Virax Biolabs Announces NASDAQ Closing Bell Ringing to Celebrate Initial Public Offering (PR Newswire) -7.70%
Jul-29-22 06:40PM	Why Virax Biolabs Stock Plummeted 74% On Friday (Motley Fool) -74.04%
Jul-26-22 08:00AM	Virax Biolabs Introduces Monkeypox and Varicella-Zoster Viruses Real-Time PCR Detection Kit (GlobeNewswire) +9.76%
Jul-21-22 10:33AM	Virax Biolabs Group Limited Completes Initial Public Offering; Shares Begin Trading Today on NASDAQ Capital Market as VRAX (GlobeNewswire)

Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

VRAX

Virax Biolabs Group Ltd

Upgrade your FINVIZ experience